Clinical trials
Completed Poliomyelitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
215 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 9 |
| 2004 | 4 |
| 2005 | 7 |
| 2006 | 18 |
| 2007 | 7 |
| 2008 | 10 |
| 2009 | 10 |
| 2010 | 12 |
| 2011 | 20 |
| 2012 | 14 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 14 |
| 2016 | 6 |
| 2017 | 14 |
| 2018 | 13 |
| 2019 | 3 |
| 2020 | 11 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 215 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 42 |
| Sanofi Pasteur, a Sanofi Company | 42 |
| Sanofi | 15 |
| Centers for Disease Control and Prevention | 12 |
| Sinovac Biotech Co., Ltd | 12 |
| Aga Khan University | 8 |
| Fidec Corporation | 7 |
| Institute of Medical Biology, Chinese Academy of Medical Sciences | 5 |
| Merck Sharp & Dohme LLC | 5 |
| PATH | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Poliomyelitis | 215 |
| Diphtheria | 102 |
| Tetanus | 99 |
| Whooping Cough | 70 |
| Haemophilus Infections | 61 |
| Hepatitis B | 59 |
| Postpoliomyelitis Syndrome | 5 |
| Bacterial Infections | 4 |
| HIV Seropositivity | 4 |
| Measles | 4 |
Trials
Showing 26 to 50 of 215. Each trial links to its page on Pharma Observatory.
115 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.